The burgeoning field of cell and gene therapy, heralded as a revolutionary frontier in medicine, is currently grappling with a…
Read More
TrumpRx.gov: A Federal Portal Faces Scrutiny Amidst Concerns Over Direct-to-Consumer Drug Sales and Patient Safety.
As of early February, the federal portal TrumpRx.gov remains in a nascent state, displaying only a stylized Oval Office portrait…
Read More
The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis
A groundbreaking shift in the understanding of weight management outcomes following the cessation of GLP-1 agonist medications is emerging, challenging…
Read More
Agentic AI-powered literature reviews: Reduce research burdens and accelerate insights
The landscape of scientific research, particularly in drug development and healthcare, is undergoing a profound transformation driven by the advent…
Read More
Rubedo Life Sciences Pioneers Senolytic Approach to Reverse Skin Aging and Treat Inflammatory Dermatoses
In a significant shift within the pharmaceutical and longevity sectors, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick…
Read More
JAMA Study Uncovers Moderate Caffeine Intake’s Link to Reduced Dementia Risk, Highlighting Adenosine Pathway for Drug Development
A comprehensive prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has revealed a significant…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
A groundbreaking international collaboration, bolstered by a prestigious pan-European EUREKA grant, has been officially announced, aiming to pioneer the development…
Read More
Closing the information gap: ETH Zürich team integrates function and binding in one drug screening assay
A groundbreaking advance in drug discovery, developed by a collaborative team from ETH Zürich and Karolinska Institutet, promises to significantly…
Read More
Can live cell dynamics fix drug discovery’s efficacy problem?
The pharmaceutical industry faces an escalating crisis of escalating costs, protracted timelines, and persistently high failure rates in bringing new…
Read More
From List Price to Net Price: How Finance Leaders Decode Real Drug Costs
In the intricate landscape of the healthcare industry, public discourse and policy debates surrounding drug pricing frequently anchor on the…
Read MoreYOU MAY HAVE MISSED
